Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep apnea, according to information sent to investors of the pharmaceutical company Eli Lilly.
April 17, 2024 –
Sleep apnea is a disorder where regular breathing is interrupted or obstructed during sleep, and it's linked to serious health problems affecting the heart, kidneys, and metabolic system. Many people with sleep apnea use a device called a continuous positive airway pressure machine while they sleep to treat the condition.came from a pair of studies that followed people with moderate to severe obstructive sleep apnea who also had obesity.
People in the study taking tirzepatide on average experienced 63% fewer instances of reduced oxygen due to breathing changes, or events when breathing entirely stopped, Eli Lilly reported. The reduction was the equivalent of 30 fewer events per hour.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA saysThe insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.
Weiterlesen »
Eli Lilly warns 2 of its insulin products may be out of stockThe shortage applies to the company's 10 mL vials of Humalog and Insulin Lispro Injection medications.
Weiterlesen »
Eli Lilly Warns That 2 Insulin Products Will Be in Short SupplyDrugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Weiterlesen »
Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and moreThese are the stocks posting the largest moves in the premarket.
Weiterlesen »
Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Weiterlesen »